Login / Signup

Metabolic control in type 2 diabetic patients treated with empagliflozin: A case series.

Wilfredo NavarretePilar DurrutyEileen AndradeRodrigo OrellanaMaría Georgina OrtizMaría Angélica Budini
Published in: Medwave (2024)
Patients with type 2 diabetes mellitus with insulin requirements treated with empagliflozin at the Peñaflor Hospital achieved better glycemic control with few adverse effects.
Keyphrases
  • glycemic control
  • type diabetes
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • blood glucose
  • weight loss
  • emergency department
  • patient reported outcomes
  • skeletal muscle